Target intelligence / Profile preview

LsrR transcriptional repressor (LsrR)

Target
LsrR
Molecular classification
Transcription factor, SorC/DeoR family
01

Overview

LsrR (LuxS-regulated repressor) is a key transcriptional regulator in the SorC/DeoR family that controls the uptake and processing of Autoinducer-2 (AI-2), a universal signal molecule for interspecies quorum sensing in bacteria such as Escherichia coli and Salmonella enterica [UniProt P0A9I0; PMID: 17233824]. In its apo-form, LsrR binds to the promoter of the lsr operon, repressing genes responsible for AI-2 transport; upon the accumulation of intracellular phospho-AI-2, the repressor dissociates, triggering a positive feedback loop of AI-2 uptake [PMID: 19321645]. This regulatory circuit is crucial for the coordination of group behaviors, including biofilm formation and the expression of virulence factors necessary for host colonization and infection [PMID: 25605310]. Because LsrR modulates pathogenicity without directly affecting bacterial viability, it is considered a high-priority target for anti-virulence therapies designed to bypass traditional antibiotic resistance mechanisms [PMID: 30256134]. Small molecules, such as AI-2 analogs and certain flavonoids like quercetin, have been shown to interact with LsrR or its signaling pathway to disrupt bacterial communication and attenuate infection [PMID: 23838290].

Other names
LuxS-regulated transcriptional repressorAutoinducer-2 repressorAI-2 repressorDeoR-family transcriptional regulator LsrR
02

Mechanism of action

Modulation of LsrR DNA-binding affinity through competitive binding or allosteric inhibition, leading to the premature or inhibited induction of the lsr operon and disruption of quorum sensing-mediated virulence.

03

Biological functions

Quorum sensingSignal transductionBacterial communicationBiofilm formationVirulence regulationAI-2 transport regulation
04

Disease associations

InfectionBacterial pathogenesis
05

Safety considerations

Off-target effects on commensal microbiotaPotential for bacterial resistance developmentBioavailability in the gastrointestinal tract
06

Interacting drugs

Quercetin

3 more in the full profile.

07

Biomarkers

Autoinducer-2 (AI-2) levelslsr operon expressionBiofilm density

Beyond the preview

Go deeper on LsrR transcriptional repressor (LsrR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LsrR transcriptional repressor (LsrR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call